-+ 0.00%
-+ 0.00%
-+ 0.00%

GSK : AZUR-1 TRIAL MET PRIMARY ENDPOINT WITH MEANINGFUL SUSTAINED CLINICAL COMPLETE RESPONSE AT 12 MONTHS

Reuters·09/24/2026 12:01:49

Please log in to view news